Prostatic Hyperplasia: Clinical Trials

10 trials for Prostatic Hyperplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 terminated. 10 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Terminated 10
Phase 11Terminated 1

Follow Prostatic Hyperplasia: new trials by email Literature Review of Prostatic Hyperplasia trials Research Report on Prostatic Hyperplasia

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients With Benign Prostatic Hyperplasia-related Obstruction
Targeted Microwave Ablation - Benign Prostatic Hyperplasia
Phase 2TerminatedAssistance Publique - Hôpitaux de Paris82024-04-242026-10-01
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
Group-1 (15mg, OPK-88004), Group-2 (25 mg,OPK-88004), Placebo - Benign Prostatic Hyperplasia
Phase 2TerminatedOPKO Health, Inc.1142018-02-212021-09-16
Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)
Embosphere microspheres - Benign Prostatic Hypertrophy, Lower Urinary Tract Symptoms
Phase 1 / Phase 2TerminatedRhode Island Hospital92015-12-012021-07-08
Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams
Embosphere Microspheres - Prostatic Hyperplasia
Phase 2TerminatedSouth Florida Medical Imaging, PA22015-09-242018-11-06
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Docetaxel, TroVax - Hormone Refractory Prostate Cancer
Phase 2TerminatedOxford BioMedica252010-08-012020-10-19
A Study in Men With Benign Prostatic Hyperplasia
LY500307, Placebo - Benign Prostatic Hyperplasia
Phase 2TerminatedEli Lilly and Company4142010-04-012019-04-08
Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)
ozarelix, Placebo - Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptoms (LUTS)
Phase 2TerminatedSpectrum Pharmaceuticals, Inc282008-12-042021-11-22
A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)
etonogestrel, Placebo - Benign Prostatic Hyperplasia (BPH)
Phase 2TerminatedOrganon and Co162008-03-012026-04-08
Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Lonidamine - Benign Prostatic Hyperplasia
Phase 2TerminatedThreshold Pharmaceuticals2402005-06-012009-04-29
Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)
Lemuteporfin for injection, Transurethral drug delivery system, Transurethral light delivery system - Prostatic Hyperplasia
Phase 2TerminatedQLT Inc.1802005-05-012006-10-03

Narrower conditions

Lower Urinary Tract Symptoms (3)  ·  Prostatic Neoplasms (1)

Broader conditions

Genital Diseases (10)  ·  Genital Diseases, Male (10)  ·  Male Urogenital Diseases (10)  ·  Prostatic Diseases (10)  ·  Urogenital Diseases (10)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Urological Manifestations (3)  ·  Genital Neoplasms, Male (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Urogenital Neoplasms (1)

Interventions

Docetaxel (1)  ·  Injections (1)  ·  TroVax (1)  ·  erteberel (1)  ·  etonogestrel (1)  ·  lemuteporfin (1)  ·  lonidamine (1)  ·  ozarelix (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Eli Lilly and Company (1)  ·  OPKO Health, Inc. (1)  ·  Organon and Co (1)  ·  Oxford BioMedica (1)  ·  QLT Inc. (1)  ·  Rhode Island Hospital (1)  ·  South Florida Medical Imaging, PA (1)  ·  Spectrum Pharmaceuticals, Inc (1)  ·  Threshold Pharmaceuticals (1)

Countries

United States (8)  ·  Canada (2)  ·  France (2)  ·  Argentina (1)  ·  Australia (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Russia (1)

Top investigators

Anna C. Ferrari, MD (1)  ·  Graeme Boniface, PhD (1)  ·  Michael Rush, MD (1)  ·  Militza Vera De Alba, MD (1)

Results publications

PMID 23877659